Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/eurheartj/ehaa608 | DOI Listing |
BMJ Case Rep
January 2024
Medicine, Wexford General Hospital, Newtown Road, Carricklawn, Wexford, Ireland.
J Interv Cardiol
March 2021
ICCU, San Giuseppe Moscati Hospital, ASL CE, Aversa, Italy.
Background: Sirolimus-coated balloons (SCBs) represent a novel therapeutic option for both in-stent restenosis (ISR) and de novo coronary lesions treatment, especially in small vessels. Our registry sought to evaluate the procedural and clinical outcomes of such devices in a complex acute coronary syndrome (ACS) clinical setting.
Methods And Results: We treated 74 consecutive patients with percutaneous coronary intervention (PCI) with at least 1 SCB used for ISR and/or de novo coronary lesion in small vessels at our institution.
Eur Heart J
December 2020
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Anatol J Cardiol
November 2020
Department of Cardiology, Ibn-i Sina Hospital, Faculty of Medicine, Ankara University, Ankara, Turkey.
Curr Hypertens Rep
October 2019
Dr. Eric Jackman Institute of Child Study, University of Toronto, 45 Walmer Rd., Toronto, ON, M5R 2X2, Canada.
Purpose Of Review: For measurement of blood pressure, using inflatable cuff-based technology can be inconvenient, uncomfortable, and requires special equipment. These issues could be overcome by using a contactless technology that measures blood pressure with the ubiquitous smartphone.
Recent Findings: In a proof of concept study involving normotensive participants, Luo et al.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!